3-108551265-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_020890.3(CIP2A):āc.2602G>Cā(p.Glu868Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000274 in 1,460,298 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 31)
Exomes š: 0.0000027 ( 0 hom. )
Consequence
CIP2A
NM_020890.3 missense
NM_020890.3 missense
Scores
3
7
9
Clinical Significance
Conservation
PhyloP100: 5.19
Genes affected
CIP2A (HGNC:29302): (cellular inhibitor of PP2A) Enables protein homodimerization activity. Predicted to act upstream of or within positive regulation of neural precursor cell proliferation and spermatogenesis. Located in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CIP2A | NM_020890.3 | c.2602G>C | p.Glu868Gln | missense_variant | 21/21 | ENST00000295746.13 | NP_065941.2 | |
CIP2A | XM_006713716.4 | c.2599G>C | p.Glu867Gln | missense_variant | 21/21 | XP_006713779.1 | ||
CIP2A | XM_011513057.3 | c.1660G>C | p.Glu554Gln | missense_variant | 14/14 | XP_011511359.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CIP2A | ENST00000295746.13 | c.2602G>C | p.Glu868Gln | missense_variant | 21/21 | 1 | NM_020890.3 | ENSP00000295746 | P1 | |
CIP2A | ENST00000491772.5 | c.2125G>C | p.Glu709Gln | missense_variant | 21/21 | 1 | ENSP00000419487 | |||
CIP2A | ENST00000481530.5 | c.*2172G>C | 3_prime_UTR_variant, NMD_transcript_variant | 21/21 | 1 | ENSP00000417297 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460298Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726460
GnomAD4 exome
AF:
AC:
4
AN:
1460298
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
726460
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2024 | The c.2602G>C (p.E868Q) alteration is located in exon 21 (coding exon 21) of the KIAA1524 gene. This alteration results from a G to C substitution at nucleotide position 2602, causing the glutamic acid (E) at amino acid position 868 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.
REVEL
Benign
Sift
Uncertain
D;D;.
Sift4G
Uncertain
D;D;D
Polyphen
D;.;.
Vest4
MutPred
Gain of glycosylation at S869 (P = 0.0075);.;.;
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.